Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 235
Filter
1.
Braz. dent. sci ; 25(1): 1-7, 2022. ilus
Article in English | LILACS, BBO | ID: biblio-1361997

ABSTRACT

Oral mucosa could be the first site infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ­the causative agent of coronavirus disease 2019 (COVID-19). Indeed, different oral and paraoral lesions, conditions and symptoms have been reported in patients with COVID-19. Experts thought that such oral lesions could be secondary to the COVID-19-associated deterioration of systemic health or due to treatments of COVID-19. We present here a case of a 24-year-old male presented with painful multiple ulcers involving the labial and buccal mucosae bilaterally after a while of feeling very mild symptoms that laboratory-confirmed by reverse-transcription polymerase chain reaction to be COVID-19. Involvement of eyes was also reported. The above clinical presentation was consistent with minor erythema multiform. Many topical preparations were prescribed but with limited improvement. Hence, oral prednisolone was prescribed with a 40-mg loading dose that was tapered by 10 mg every 3 days. Complete healing of oral mucosa was observed on the 10 day. Strikingly, the patient got affected with the second episode of similar oral lesions 5 months later without any apparent triggering factors, suggestive a long term effects of COVID-19 in a subset of patients. The present case report provides dentists with useful information and increases their awareness regarding possible involvement of oral cavity with multiple ulcerative lesions associated with COVID-19 (AU)


A mucosa oral pode ser o primeiro local infectado com a síndrome respiratória aguda grave coronavírus 2 (SARS- CoV-2) ­ o agente causador da doença por coronavírus 2019 (COVID-19). De fato, diferentes lesões, condições e sintomas orais e paraorais foram relatados em pacientes com COVID-19. Os especialistas pensavam que essas lesões orais poderiam ser secundárias à deterioração da saúde sistêmica associada ao COVID-19 ou devido a tratamentos do COVID-19. Apresentamos aqui um caso de um homem de 24 anos que apresentou múltiplas úlceras dolorosas envolvendo bilateralmente as mucosas labial e bucal após um tempo sentindo sintomas muito leves que foram confirmados laboratorialmente pela reação em cadeia da polimerase de transcrição reversa como COVID-19. O envolvimento dos olhos também foi relatado. A apresentação clínica acima foi compatível com eritema multiforme menor. Muitas preparações tópicas foram prescritas, mas com melhora limitada. Assim, foi prescrito prednisolona oral com uma dose inicial de 40 mg que foi reduzida em 10 mg a cada 3 dias. A cicatrização completa da mucosa oral foi observada no 10º dia. Surpreendentemente, o paciente foi afetado com o segundo episódio de lesões orais semelhantes 5 meses depois, sem nenhum fator desencadeante aparente, sugerindo efeitos de longo prazo do COVID-19 em um subconjunto de pacientes. O presente relato de caso fornece aos dentistas informações úteis e aumenta sua conscientização sobre o possível envolvimento da cavidade oral com múltiplas lesões ulcerativas associadas ao COVID-19 (AU)


Subject(s)
Humans , Male , Adult , Oral Manifestations , Erythema Multiforme , COVID-19
2.
Arq. odontol ; 58: 57-62, 2022. ilus
Article in Portuguese | LILACS, BBO | ID: biblio-1380553

ABSTRACT

Objetivo: Este trabalho tem como objetivo relatar um caso de Eritema Multiforme (EM) menor desencadeado por amoxicilina oral, tratado a partir de aplicação de laser de baixa intensidade na região afetada pela doença. Relato de caso: Paciente de 12 anos, atendido no Hospital Metropolitano Odilon Behrens (HMOB), apresentando úlceras em mucosa jugal, lábios e língua, disfagia, dislalia e febre, recebeu diagnóstico clínico de EM e tratamento com aplicação de laser vermelho de baixa intensidade, emitindo em 660nm, com potência de 100mW, sendo aplicado uma dose de 33 J/cm², em pontos com distância aproximada de 1 cm entre eles. Houve resolução das lesões em 7 dias após instituição do tratamento. Conclusão: O presente trabalho mostrou que a Terapia de Fotobiomodulação (TF) com laser de baixa intensidade associado à substituição do medicamento detectado como causa foram fundamentais para a resolução do EM, evidenciando as propriedades bioestimulantes do laser nas lesões ulceradas de mucosa bucal.


Aim: This paper aims to report a case of minor Erythema Multiforme (EM) triggered by oral amoxicillin, treated with low-level laser applications in the region affected by the disease. Case report: A 12-year-old patient, treated at the Metropolitan Hospital Odilon Behrens, presenting ulcers in the buccal mucosa, lips, tongue, dysphagia, dyslalia, and fever, received a clinical diagnosis of EM and treatment with low-intensity red laser applications, emitted at 660 nm, with a power of 100 mW, with a dose of 33 J/cm² being applied, in points with an approximate distance of 1 cm between them. The lesions resolved within 7 days after treatment were instituted. Conclusion: This present paper shows a successful therapeutic, non-pharmacological alternative for the management of EM, showing the bio stimulating properties of laser in ulcerated lesions of the oral mucosa.


Subject(s)
Autoimmune Diseases , Erythema Multiforme , Oral Ulcer , Low-Level Light Therapy
3.
Rev. méd. Chile ; 148(11)nov. 2020.
Article in Spanish | LILACS | ID: biblio-1389256

ABSTRACT

Rowell's syndrome is characterized by an association of lupus erythematosus and erythema multiforme, with distinctive laboratory findings. Its treatment is similar to lupus. We report a 16-year-old female presenting with skin lesions, laboratory and histology consistent with this entity. Because of the spread of cutaneous involvement and development of epidermal detachment, she required therapy with intravenous corticosteroids and gamma globulin.


Subject(s)
Adolescent , Female , Humans , Lupus Erythematosus, Cutaneous , Erythema Multiforme , Lupus Erythematosus, Systemic , Syndrome , Lupus Erythematosus, Cutaneous/diagnosis , Erythema Multiforme/diagnosis , Adrenal Cortex Hormones , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/drug therapy
4.
Arq. bras. med. vet. zootec. (Online) ; 72(3): 911-914, May-June, 2020. ilus
Article in Portuguese | LILACS, VETINDEX | ID: biblio-1129593

ABSTRACT

O eritema multiforme é uma doença incomum em cães, que afeta pele e mucosas, cuja etiologia ainda não foi completamente elucidada. Contudo, o envolvimento exclusivo da cavidade oral é considerado raro, tendo sido descrito poucas vezes até o presente momento. O objetivo deste trabalho é descrever um caso de eritema multiforme limitado à cavidade oral em um canino. Um cão, fêmea, Akita, com sete anos de idade, apresentou histórico de ulcerações na cavidade oral e nas laterais da língua, sem alterações cutâneas ou sistêmicas. O diagnóstico definitivo foi realizado por meio do exame histopatológico da mucosa oral, e a terapia imunossupressora empregada mostrou-se eficaz. Embora o eritema multiforme seja considerado incomum na espécie canina, este relato de caso apresenta a forma mais rara da doença, com poucos casos descritos em medicina veterinária.(AU)


Multiforme erythema is an uncommon disease in dogs that affects the skin and mucous membranes, the etiology of which has not yet been fully elucidated. However, the exclusive involvement of the oral cavity is considered rare, having been described few times until the present moment. The aim of this work is to describe a case of multiforme erythema limited to the oral cavity in a canine. A seven-year-old female dog, akita, presented a history of ulcerations in the oral cavity and on the sides of the tongue, with no cutaneous or systemic changes. The definitive diagnosis was made through the histopathological examination of the oral mucosa and the immunosuppressive therapy used proved to be effective. Although multiforme erythema is considered uncommon in the canine species, this case report presents the rarest form of the disease, with few cases described in veterinary medicine.(AU)


Subject(s)
Animals , Dogs , Stomatitis/veterinary , Erythema Multiforme/veterinary , Mouth/pathology , Tongue , Immunosuppressive Agents/administration & dosage
5.
Arq. Asma, Alerg. Imunol ; 4(2): 213-215, abr.jun.2020. ilus
Article in English | LILACS | ID: biblio-1381929

ABSTRACT

Erythema multiforme is generally associated with infections and drugs. Although less common, there are also reported cases of this disorder after patch testing. We described a 22 year-old female patient who, 24 hours after patch testing, progressed to erythematous iris-shaped plaques and papules with central crust, symmetrically distributed over her hands, arms, and back, with severe itch. The erythema multiforme-like lesions presented in the case were interpreted as a manifestation of systemic allergic contact dermatitis secondary to the exam. Allergic contact dermatitis may be manifested as an erythema multiforme in a hypersensitive person. Few cases of systemic allergic contact dermatitis after patch testing have been reported, for example, due to diethyl thiourea, some textile disperse dyes, and povidoneiodine. The development of erythema multiforme is not noted in most literature references as a complication after patch testing. Although unusual, this disorder needs to be considered as a potential adverse effect of this exam.


O eritema multiforme está associado comumente a infecções e medicamentos. Embora menos comum, também há casos relatados dessa doença após aplicação do teste de contato. Descrevemos uma paciente de 22 anos que evoluiu, em 24 horas após o teste, com placas e pápulas eritematosas, em formato de íris e crosta central, distribuídas simetricamente nas mãos, braços e costas, além de prurido intenso. As lesões eritema multiformesímile presentes no caso foram interpretadas como uma manifestação alérgica secundária ao exame. Dermatite de contato alérgica pode se manifestar como um eritema multiforme em pessoas hipersensíveis. Poucos casos de dermatite alérgica de contato sistêmica foram relatados após este exame, por exemplo, devido às seguintes substâncias: dietil tioureia, corantes dispersos têxteis e iodopovidona. O desenvolvimento do eritema multiforme não é usualmente apontado como uma complicação do teste de contato alérgico, na maioria das referências literárias. Embora incomum, o surgimento dessa desordem após este exame necessita ser considerado como um efeito adverso.


Subject(s)
Humans , Female , Young Adult , Patch Tests , Patch Tests/adverse effects , Erythema Multiforme , Dermatitis, Allergic Contact , Arm , Pruritus , Back , Prednisolone , Coloring Agents , Hand
6.
Journal of the Philippine Dermatological Society ; : 59-62, 2020.
Article in English | WPRIM | ID: wpr-876401

ABSTRACT

@#Introduction: Erythema multiforme has been known as an infection or drug-associated mucocutaneous eruption characterized by target lesions. A clinical entity, known as Mycoplasma-induced rash and mucositis seen mostly in the pediatric population is emerging and may be associated with atypical pneumonia caused by Mycoplasma pneumoniae. This presents with features overlapping with erythema multiforme and SJS-TEN spectrum but with a different trigger, prognosis, and recurrence rate. Case summary: Target lesions in the clinical setting are usually characteristically associated with erythema multiforme, a mucocutaneous condition associated with an underlying infectious trigger. We present a case of a 10-year-old Filipino boy who was initially diagnosed with erythema multiforme major. Eventual testing for the etiology of the underlying infection, Mycoplasma pneumoniae, proved to be a useful diagnostic that gave a better grasp on the case’s mechanism, sequela, and prognosis. The patient was admitted for pneumonia and his presenting mucositis was severe. Cutaneously, he had atypical target and few target lesions on the trunk and extremities. He was diagnosed as a case of Mycoplasma-induced rash and mucositis (MIRM) and treated with antibiotics and systemic steroids for which he recovered fully in three weeks. MIRM should be separated from erythema multiforme, Stevens Johnsons syndrome and toxic epidermal necrolysis as it follows a different disease course. Conclusion: Mycoplasma-induced rash and mucositis is now considered a distinct entity despite it having overlapping features with erythema multiforme and SJS-TEN spectrum. It presents usually in the younger age group with absent to sparse atypical vesiculobullous or targetoid lesions, significant mucosal involvement, and confluent necrosis on histology. It is important to identify it as a trigger because of its more frequent and severe mucosal sequelae. Management includes symptomatic relief, antibiotic therapy with a macrolide in the presence of pneumonia and systemic steroids when mucositis is severe. Majority of patients achieve full recovery.


Subject(s)
Erythema Multiforme , Mycoplasma pneumoniae , Mucositis , Exanthema
8.
Korean Journal of Dermatology ; : 32-35, 2019.
Article in Korean | WPRIM | ID: wpr-719525

ABSTRACT

Urticaria multiforme is a cutaneous condition observed in children. This self-limited condition is characterized by well-circumscribed, annular, and erythematous wheals, which spontaneously disappear within a few days. Patients commonly present with acral edema and show a favorable response to antihistamines. It is frequently misdiagnosed as erythema multiforme or serum sickness-like reaction owing to distinctive annular wheals with an ecchymotic center observed in patients. This condition was previously known as acute annular urticaria. The term urticaria multiforme was introduced in 2007 to highlight this specific variant of urticaria. We describe 2 patients with acral edema and transient annular wheals with dusky red centers, which were diagnosed as urticaria multiforme lesions. To our knowledge, the Korean literature includes only a single case report describing acute annular urticaria. However, the report does not use the term ‘urticaria multiforme’ to describe this condition.


Subject(s)
Child , Humans , Edema , Erythema Multiforme , Histamine Antagonists , Pigmentation , Urticaria
9.
Rev. argent. mastología ; 37(135): 52-57, jul. 2018. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-1118015

ABSTRACT

Paciente femenino de 23 años, sin antecedentes de relevancia, que comienza con cuadro progresivo de múltiples lesiones eritematosas en mama derecha sin comprometer ninguna otra localización. Se realiza tratamiento antibiótico sin mejoría clínica, por lo que se decide internación y toma de biopsia cutánea. La paciente comienza con cuadro neurológico progresivo homolateral al compromiso mamario, con dificultad respiratoria, parestesias bucales, alopecía parcheada y dificultad a la marcha con debilidad funcional homolateral. Se solicitan estudios complementarios de imágenes y laboratorio con resultados dentro de parámetros normales. El resultado de la biopsia informa "Eritema multiforme". Se indica tratamiento psiquiátrico para el componente neurológico y tratamiento sintomático para su patología de base, obteniéndose curación completa en 21 días.


23-year-old female patient, with no relevant medical history, starts with multiple progressive erythematous lesions in the right breast without compromising any other location. An antibiotic treatment is started without clinical improvement, so it's decided to hospitalize and take a skin biopsy. During her stay, the patient begins with ipsilateral progressive neurological symptoms, including respiratory distress, oral paresthesia, alopecía, walking difficulties, among others. cat, mri, laboratory and other test are requested with no abnormal results. The skin biopsy reports Erythema Multiforme. A psychiatric treatment is started for the neurological component and symptomatic treatment for the em, obtaining complete cure in 21 days.


Subject(s)
Humans , Female , Autoimmune Diseases , Erythema Multiforme , Dermatology
11.
Actas odontol ; 14(1): 50-56, jul. 2017. ilus, tab
Article in Spanish | LILACS, BNUY | ID: biblio-982602

ABSTRACT

El Eritema Multiforme (EM) es una reacción poco común, aguda, de piel y mucosa. Es una reacción de hipersensibilidad, caracterizada por erupciones en piel en forma de diana, constituidas por zonas concéntricas de diferente coloración, y lesiones ulcerosas o vesículo-ampollares en mucosa. La enfermedad puede ser desencadenada por infecciones, principalmente por virus del herpes simple (HSV) y Mycoplasma pneumoniae y por ingestión de drogas, siendo las más frecuentes las sulfonamidas y las penicilinas. Se presentan tres casos relacionados a la infección por el virus del herpes simple.


Erythema multiforme (EM) is a condition acute, mucocutaneous, caused by hypersensitivity reaction, characterized by skin eruption (target lesions with concentric zones) and mucous membrane lesions (ulcerous, bullous-vesicular lesions). The disorder can be induced by infections, particularly herpes simplex(VSH) and Mycoplasma pneumoniae, or by drug intake (AINE, sulfonamides, penicillin’s) Three cases related to VHS infection, are presented.


Subject(s)
Humans , Male , Female , Adolescent , Erythema Multiforme/diagnosis , Erythema Multiforme/drug therapy , Erythema Multiforme/etiology , Erythema Multiforme/pathology , Antiviral Agents/therapeutic use , Herpes Simplex/complications , Herpes Simplex/drug therapy , Mouth/injuries
12.
Annals of Dermatology ; : 479-482, 2017.
Article in English | WPRIM | ID: wpr-86510

ABSTRACT

Autoimmune progesterone dermatitis is a rare cyclic premenstrual reaction to progesterone produced during the luteal phase of the menstrual cycle. The clinical symptoms of autoimmune progesterone dermatitis overlap with other forms of dermatosis such as erythema multiforme, eczema, fixed drug eruption, urticaria, and angioedema. We experienced 3 cases of autoimmune progesterone dermatitis. All patients had a recurrent history of monthly skin eruptions. Skin lesions normally began a few days before menstruation and resolved a few days later. Patients were confirmed to have autoimmune progesterone dermatitis by the results of the progesterone intradermal test. All three patients had different clinical findings such as erythema annulare centrifugum, urticaria, contact dermatitis, and rosacea. Because patients presented with variable clinical manifestations, they could have been easily misdiagnosed. The patients were treated with oral contraceptive, antihistamine and steroids for symptom control. We propose that dermatologists should consider autoimmune progesterone dermatitis in cases of recurrent cyclic skin eruptions in female patients. Further, if this condition is suspected, thorough history taking including that on menstrual cycle and intradermal progesterone test should be performed.


Subject(s)
Female , Humans , Angioedema , Dermatitis , Dermatitis, Contact , Drug Eruptions , Eczema , Erythema , Erythema Multiforme , Intradermal Tests , Luteal Phase , Menstrual Cycle , Menstruation , Progesterone , Rosacea , Skin , Skin Diseases , Steroids , Urticaria
13.
Korean Journal of Dermatology ; : 186-190, 2017.
Article in Korean | WPRIM | ID: wpr-33716

ABSTRACT

Mycoplasma pneumoniae (M. pneumoniae) is one of the most common causes of respiratory tract infections in pediatric and adult populations worldwide. M. pneumoniae is also associated with extrapulmonary complications, such as mucocutaneous eruptions. In dermatologic disorders, M. pneumoniae infection is known to be associated with erythema multiforme and Stevens-Johnson syndrome in children and young adults. Recently, several cases with M. pneumoniae-associated mucositis, which lacks typical target lesions, have been reported. The term Mycoplasma-induced rash and mucositis was suggested as a revised version of the term, Mycoplasma pneumoniae-associated mucocutaneous disease, which previously included erythema multiforme and Stevens-Johnsons syndrome. This revision helps to distinguish Mycoplasma-induced rash and mucositis, which has a distinct morphology, mild disease course, and potentially important clinical implications regarding treatment. Herein, we report a patient with Mycoplasma-induced rash and mucositis.


Subject(s)
Adult , Child , Humans , Young Adult , Erythema Multiforme , Exanthema , Mucositis , Mycoplasma pneumoniae , Mycoplasma , Pneumonia , Pneumonia, Mycoplasma , Respiratory Tract Infections , Stevens-Johnson Syndrome
14.
Korean Journal of Dermatology ; : 212-213, 2017.
Article in Korean | WPRIM | ID: wpr-53853

ABSTRACT

No abstract available.


Subject(s)
Erythema Multiforme , Erythema , Pemphigoid, Bullous
15.
Horiz. méd. (Impresa) ; 16(2): 77-81, abr.-jun. 2016. ilus
Article in Spanish | LILACS, LIPECS | ID: biblio-834611

ABSTRACT

El eritema multiforme (EM) es una reacción de hipersensibilidad que afecta a la piel y / oa las membranas mucosas, en respuesta a infecciones, fármacos u otras comorbilidades. La presentación de EM puede ser Menor (EM leve, caracterizada por presentar lesiones diana) o Mayor (EM severa, que también ocurre con afectación de las membranas mucosas). Se presenta el caso de un paciente varón de 36 años de edad que presenta una emergencia de HNAL con fiebre, malestar, prurito y lesiones dolorosas en la cavidad oral, lesiones múltiples en miembros superiores e inferiores, pene y región perianal. El diagnóstico fue EM Major. Las lesiones ulcerosas en la cavidad oral y las lesiones diana en las manos fueron las más destacadas.


Erythema multiforme (EM) is a hypersensitivity reaction that affects the skin and/or mucous membranes, in response to infections, drugs, or other comorbidities. Presentation of EM can be Minor (Mild EM, characterized for presenting target lesions) or Major (Severe EM, that occurs also with mucous membranes involvement). The case of a 36 year old male patient presenting to emergency of HNAL with fever, malaise, itching and painful ulcer type lesions in oral cavity, multiple target lesions in upper and lower limbs, penis, and perianal region is reported. The diagnosis was EM Major. Ulcerous lesions in oral cavity and target lesions in hands were the most salient.


Subject(s)
Humans , Male , Adult , Erythema Multiforme , Herpes Zoster
16.
Rev. Nac. (Itauguá) ; 8(2): 04-18, dic 2016.
Article in Spanish | LILACS, BDNPAR | ID: biblio-884748

ABSTRACT

Introducción la lepra, llamada también enfermedad de Hansen, es una afección de la piel y de los nervios periféricos, infectocontagiosa, causada por Mycobacterium leprae. Las reacciones lepromatosas se presentan aún con tratamiento y son expresiones de respuesta inmunitaria. Conocerlas es importante a fin de facilitar el abordaje. Objetivo determinar la frecuencia y tipo de reacciones lepromatosas en pacientes con diagnóstico de lepra que acuden al centro de referencia de Enfermedad de Hansen en el Hospital Distrital de San Lorenzo, de enero 2013 a diciembre 2015. Metodología observacional, descriptivo, retrospectivo de corte transverso. Resultados se incluyeron 217 pacientes, 72% presentaban lepra MB y 63% era de sexo masculino. La prevalencia de reacción lepromatosa fue 44%, siendo más frecuentes las de tipo 2 (65%). Se presentó reacción lepromatosa como debut de la enfermedad en 27 %. Treinta y tres pacientes presentaron de tres a doce episodios de reacción lepromatosa. El tratamiento fue talidomida y corticoides. Conclusiones la prevalencia de leprorreacciones fue cercana al 50%, predominando las de tipo 2. El tratamiento utilizado fue talidomida y/o corticoides dependiendo del tipo de reacción lepromatosa.


Introduction leprosy, wich is cause by Mycobacterium leprae, also known as Hansen's Disease, affects skin and peripheral nerves. Lepromatous reactions (LRs) are expressions of an immune reaction and remain as a major persistent problem. LRs are present even with appropriated treatment. Emphasis must be made in early diagnosis and prevention of the catastrophic consequences of LRs. Objective to determine the frequency and type of lepromatous reactions in leprosy patients with leprosy attending to reference center of Hansen´s Disease in the District Center Hospital in San Lorenzo, from January 2013 to December 2015. Methodology observational, retrospective cross sectional study. Results 217 patients were included, 72% with multibacillary leprosy. 63% were male. Lepromatous reactions were found in 44%, been more frequent Type II reaction, in 65% of cases. LRs as oset disease occurred in 27%. 33 patients presented from 3 to 12 episodes of lepromatous reaction. The number of LRs episodes per patient were 3 to 12. Thalidomide was used as treatment in Erithema Nodosum Leprosum (ENL) and corticosteroids for the other types de LRs. Conclusions prevalence of PRs were 50%, been more frecuent the type II. Reaction the treatment used was Thalidomide and/or corticosteroids depending on the type of lepromatosus reaction.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Leprosy, Multibacillary/physiopathology , Leprosy, Multibacillary/epidemiology , Leprosy, Paucibacillary/physiopathology , Leprosy, Paucibacillary/epidemiology , Paraguay/epidemiology , Thalidomide/therapeutic use , Prevalence , Cross-Sectional Studies , Retrospective Studies , Erythema Multiforme/drug therapy , Erythema Multiforme/epidemiology , Adrenal Cortex Hormones/therapeutic use , Erythema Nodosum/drug therapy , Erythema Nodosum/epidemiology , Leprosy, Multibacillary/drug therapy , Leprosy, Paucibacillary/drug therapy
17.
Korean Journal of Dermatology ; : 136-140, 2016.
Article in Korean | WPRIM | ID: wpr-73822

ABSTRACT

Sorafenib is an oral, multi-targeted tyrosine kinase inhibitor with anti-angiogenic and anti-proliferative activity. It is approved for the treatment of unresectable hepatocellular and advanced renal carcinomas. Cutaneous toxicity is relatively common in patients receiving sorafenib. The most frequent cutaneous side effect is the hand-foot syndrome. Other adverse skin reactions include facial erythema, acral erythema, erythema multiforme, subungual splinter hemorrhage, stomatitis, and alopecia. In Korea, two cases of scrotal and perianal dermatitis after sorafenib therapy were reported. We report a 54-year-old male patient with a 2-week history of scrotal eczema who had been treated for chronic hepatitis type B, liver cirrhosis, and hepatocellular carcinoma. After 2 weeks of oral sorafenib (800 mg/day) administration, thick, scaly patches appeared on his scrotum. A skin biopsy specimen from these lesions revealed superficial dermal perivascular lymphocytic and neutrophilic infiltration, and dilatation of the lymphatics in the superficial dermis. The lesions improved after treatment with a topical and systemic steroid for 2 weeks. Herein, we report a rare case of scrotal erythema associated with sorafenib.


Subject(s)
Humans , Male , Middle Aged , Alopecia , Biopsy , Carcinoma, Hepatocellular , Dermatitis , Dermis , Dilatation , Eczema , Erythema Multiforme , Erythema , Hand-Foot Syndrome , Hemorrhage , Hepatitis, Chronic , Korea , Liver Cirrhosis , Neutrophils , Protein-Tyrosine Kinases , Scrotum , Skin , Stomatitis
18.
Korean Journal of Dermatology ; : 590-592, 2016.
Article in English | WPRIM | ID: wpr-67135

ABSTRACT

No abstract available.


Subject(s)
Cluster Headache , Erythema Multiforme , Erythema , Herpes Simplex
19.
Dermatol. argent ; 21(2): 138-141, abr.jun.2015.
Article in Spanish | LILACS | ID: lil-781808

ABSTRACT

El eritema multiforme (EM) es una reacción aguda de la piel que agrupa un amplio espectro de lesiones cutáneas con diferentes grados de severidad clínica. Su evolución es por lo general benigna, recurrente y de remisión espontánea. Presentamos un caso de EM ampollar secundario a infección por virus herpes simple, una variedad poco frecuente, que puede ser difícil de diferenciar de otras patologías ampollares, llevando a diagnósticos erróneos y tardíos...


Subject(s)
Humans , Erythema Multiforme , Herpes Simplex , Infections , Skin , Viruses
20.
Annals of Dermatology ; : 97-98, 2015.
Article in English | WPRIM | ID: wpr-202022

ABSTRACT

No abstract available.


Subject(s)
Erythema Multiforme
SELECTION OF CITATIONS
SEARCH DETAIL